— Know what they know.
Not Investment Advice

ENTX NASDAQ

Entera Bio Ltd.
1W: +4.0% 1M: -2.0% 3M: +67.2% YTD: +61.6% 1Y: +54.6% 3Y: +297.8% 5Y: -40.5%
$2.86
-0.03 (-1.04%)
 
Weekly Expected Move ±6.8%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 37 · $141.0M mcap · 40M float · 4.74% daily turnover · Short 38% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-100.0% YoY
$-17M
Net Income
-60.7% YoY
$-11M
Free Cash Flow
-69.9% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-138.9%
ROA-87.0%
ROIC314.4%

Valuation

P/E-8.2
P/B19.9
EV/EBITDA-5.5

Leverage

Debt/Equity0.06
Current Ratio8.98
Interest Cov.-5.2x

Quality Scores

Piotroski F1/9
Altman Z-6.79
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms